tiprankstipranks
Trending News
More News >
Hansa Biopharma AB (SE:HNSA)
:HNSA
Sweden Market

Hansa Biopharma AB (HNSA) Cash flow

Compare
13 Followers

Hansa Biopharma AB Cash Flow

SE:HNSA's free cash flow for Q3 2025 was kr-89.68M. For the 2025 fiscal year, SE:HNSA's free cash flow was decreased by kr80.94M and operating cash flow was kr-89.68M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
kr -674.88Mkr -755.65Mkr -502.73Mkr -481.17Mkr -290.27M
Investing Cash Flow
kr -116.00Kkr -284.00Kkr 229.31Mkr -2.40Mkr 182.53M
Financing Cash Flow
kr 346.81Mkr -7.54Mkr 1.12Bkr -4.86Mkr 1.07B
End Cash Position
kr 405.28Mkr 732.06Mkr 1.50Bkr 651.34Mkr 1.14B
Free Cash Flow
kr -675.00Mkr -755.94Mkr -506.06Mkr -483.57Mkr -290.57M
Currency in SEK

Hansa Biopharma AB Cash Flow